These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
510 related items for PubMed ID: 12888890
1. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo. Riedel F, Götte K, Li M, Hörmann K, Grandis JR. Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890 [Abstract] [Full Text] [Related]
2. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration. Riedel F, Götte K, Li M, Hörmann K, Grandis JR. Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543 [Abstract] [Full Text] [Related]
3. Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy. Riedel F, Götte K, Hörmann K, Grandis JR. Adv Otorhinolaryngol; 2005 Jul; 62():103-20. PubMed ID: 15608422 [Abstract] [Full Text] [Related]
4. Targeting chemotherapy-induced VEGF up-regulation by VEGF antisense oligonucleotides in HNSCC cell lines. Riedel F, Götte K, Goessler U, Sadick H, Hörmann K. Anticancer Res; 2004 Jul; 24(4):2179-83. PubMed ID: 15330158 [Abstract] [Full Text] [Related]
5. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer. Bran B, Bran G, Hörmann K, Riedel F. Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496 [Abstract] [Full Text] [Related]
6. Antisense RNA to eIF4E suppresses oncogenic properties of a head and neck squamous cell carcinoma cell line. DeFatta RJ, Nathan CO, De Benedetti A. Laryngoscope; 2000 Jun; 110(6):928-33. PubMed ID: 10852506 [Abstract] [Full Text] [Related]
7. Tgf-beta antisense therapy increases angiogenic potential in human keratinocytes in vitro. Riedel K, Riedel F, Goessler UR, Germann G, Sauerbier M. Arch Med Res; 2007 Jan; 38(1):45-51. PubMed ID: 17174722 [Abstract] [Full Text] [Related]
8. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S, Herlyn M. Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212 [Abstract] [Full Text] [Related]
9. Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas. Benefield J, Petruzzelli GJ, Fowler S, Taitz A, Kalkanis J, Young MR. Invasion Metastasis; 1996 Apr; 16(6):291-301. PubMed ID: 9371228 [Abstract] [Full Text] [Related]
10. Abrogation of TGF-beta by antisense oligonucleotides modulates expression of VEGF and increases angiogenic potential in isolated fibroblasts from radiated skin. Riedel K, Koellensperger E, Ryssel H, Riedel F, Goessler UR, Germann G, Kremer T. Int J Mol Med; 2008 Oct; 22(4):473-80. PubMed ID: 18813854 [Abstract] [Full Text] [Related]
11. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells. Ciardiello F, Bianco R, Damiano V, Fontanini G, Caputo R, Pomatico G, De Placido S, Bianco AR, Mendelsohn J, Tortora G. Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768 [Abstract] [Full Text] [Related]
12. IL-6 antisense-mediated growth inhibition in a head and neck squamous cell carcinoma cell line. Bran G, Götte K, Riedel K, Hörmann K, Riedel F. In Vivo; 2011 Sep; 25(4):579-84. PubMed ID: 21708999 [Abstract] [Full Text] [Related]
13. Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma. Masuda M, Ruan HY, Ito A, Nakashima T, Toh S, Wakasaki T, Yasumatsu R, Kutratomi Y, Komune S, Weinstein IB. Oral Oncol; 2007 Sep; 43(8):785-90. PubMed ID: 17169602 [Abstract] [Full Text] [Related]
14. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Neuchrist C, Erovic BM, Handisurya A, Fischer MB, Steiner GE, Hollemann D, Gedlicka C, Saaristo A, Burian M. Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238 [Abstract] [Full Text] [Related]
15. Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma. Worden B, Yang XP, Lee TL, Bagain L, Yeh NT, Cohen JG, Van Waes C, Chen Z. Cancer Res; 2005 Aug 15; 65(16):7071-80. PubMed ID: 16103054 [Abstract] [Full Text] [Related]
16. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Fujiwara M, Muragaki Y, Ooshima A. Arch Dermatol Res; 2005 Oct 15; 297(4):161-9. PubMed ID: 16184401 [Abstract] [Full Text] [Related]
17. Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma. Lalla RV, Boisoneau DS, Spiro JD, Kreutzer DL. Arch Otolaryngol Head Neck Surg; 2003 Aug 15; 129(8):882-8. PubMed ID: 12925349 [Abstract] [Full Text] [Related]
18. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, Enamorado I, Yeh NT, Kroog GS, Rudy S, McCullagh L, Mousa S, Quezado M, Herscher LL, Van Waes C. Clin Cancer Res; 1999 Jun 15; 5(6):1369-79. PubMed ID: 10389921 [Abstract] [Full Text] [Related]
19. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production. Zeng G, Gao L, Birklé S, Yu RK. Cancer Res; 2000 Dec 01; 60(23):6670-6. PubMed ID: 11118051 [Abstract] [Full Text] [Related]
20. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Nör JE, Christensen J, Liu J, Peters M, Mooney DJ, Strieter RM, Polverini PJ. Cancer Res; 2001 Mar 01; 61(5):2183-8. PubMed ID: 11280784 [Abstract] [Full Text] [Related] Page: [Next] [New Search]